WordNet

any malignant tumor derived from epithelial tissue; one of the four major types of cancer
of or relating to the nervous and endocrine systems (especially as they function together)

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

Influence of tumour size on the efficacy of targeted alpha therapy with (213)Bi-[DOTA(0),Tyr(3)]-octreotate.

Chan HS1, Konijnenberg MW2, de Blois E2, Koelewijn S2, Baum RP3, Morgenstern A4, Bruchertseifer F4, Breeman WA2, de Jong M2,5.
EJNMMI research.EJNMMI Res.2016 Dec;6(1):6. doi: 10.1186/s13550-016-0162-2. Epub 2016 Jan 20.
BACKGROUND: Targeted alpha therapy has been postulated to have great potential for the treatment of small clusters of tumour cells as well as small metastases. (213)Bismuth, an α-emitter with a half-life of 46 min, has shown to be effective in preclinical as well as in clinical applications. In th
PMID 26791386

Adachi T1, Haraguchi M2, Irie J3, Yoshimoto T1, Uehara R4, Ito S1, Tokai H1, Noda K1, Tada N1, Hirabaru M1, Inoue K1, Minami S1, Eguchi S5.
Surgical case reports.Surg Case Rep.2016 Dec;2(1):71. doi: 10.1186/s40792-016-0200-3. Epub 2016 Jul 25.
Gallbladder small cell carcinoma (SCC) comprises only 0.5 % of all gallbladder cancer and consists of aggressive tumors with poor survival outcomes against current treatments. These tumors are most common in elderly females, particularly those with cholecystolithiasis. We report the case of a 79-ye
PMID 27457076

Amrubicin in patients with platinum-refractory metastatic neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the gastrointestinal tract.

Araki T1, Takashima A, Hamaguchi T, Honma Y, Iwasa S, Okita N, Kato K, Yamada Y, Hashimoto H, Taniguchi H, Kushima R, Nakao K, Boku N, Shimada Y.
Anti-cancer drugs.Anticancer Drugs.2016 Sep;27(8):794-9. doi: 10.1097/CAD.0000000000000393.
Although the same treatment strategy as used for small cell lung cancer, including second-line chemotherapy, is generally applied to metastatic neuroendocrine carcinoma (NEC) and mixed adenoneuroendocrine carcinoma (MANEC) of the gastrointestinal tract (GIT; GIT-NEC/MANEC), the efficacy of amrubicin
PMID 27341105